China · Delayed Price · Currency is CNY Enwei Pharmaceutical Statistics
Total Valuation
SHE:301331 has a market cap or net worth of CNY 3.19 billion. The enterprise value is 2.84 billion.
| Market Cap | 3.19B |
| Enterprise Value | 2.84B |
Important Dates
The next estimated earnings date is Friday, October 24, 2025.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
SHE:301331 has 101.08 million shares outstanding. The number of shares has decreased by -2.14% in one year.
| Current Share Class | 101.08M |
| Shares Outstanding | 101.08M |
| Shares Change (YoY) | -2.14% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 3.00% |
| Float | 23.68M |
Valuation Ratios
The trailing PE ratio is 54.60.
| PE Ratio | 54.60 |
| Forward PE | n/a |
| PS Ratio | 3.66 |
| PB Ratio | 2.95 |
| P/TBV Ratio | 3.73 |
| P/FCF Ratio | 352.76 |
| P/OCF Ratio | 50.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.35, with an EV/FCF ratio of 313.64.
| EV / Earnings | 49.04 |
| EV / Sales | 3.25 |
| EV / EBITDA | 25.35 |
| EV / EBIT | 43.27 |
| EV / FCF | 313.64 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.17.
| Current Ratio | 4.11 |
| Quick Ratio | 3.53 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 19.98 |
| Interest Coverage | 19.54 |
Financial Efficiency
Return on equity (ROE) is 5.52% and return on invested capital (ROIC) is 3.28%.
| Return on Equity (ROE) | 5.52% |
| Return on Assets (ROA) | 2.75% |
| Return on Invested Capital (ROIC) | 3.28% |
| Return on Capital Employed (ROCE) | 5.11% |
| Revenue Per Employee | 564,082 |
| Profits Per Employee | 37,408 |
| Employee Count | 1,548 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.69 |
Taxes
In the past 12 months, SHE:301331 has paid 11.57 million in taxes.
| Income Tax | 11.57M |
| Effective Tax Rate | 16.65% |
Stock Price Statistics
The stock price has increased by +47.04% in the last 52 weeks. The beta is 0.75, so SHE:301331's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +47.04% |
| 50-Day Moving Average | 35.41 |
| 200-Day Moving Average | 28.67 |
| Relative Strength Index (RSI) | 37.06 |
| Average Volume (20 Days) | 1,108,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301331 had revenue of CNY 873.20 million and earned 57.91 million in profits. Earnings per share was 0.58.
| Revenue | 873.20M |
| Gross Profit | 428.79M |
| Operating Income | 65.63M |
| Pretax Income | 69.48M |
| Net Income | 57.91M |
| EBITDA | 110.75M |
| EBIT | 65.63M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 535.07 million in cash and 180.87 million in debt, giving a net cash position of 354.21 million or 3.50 per share.
| Cash & Cash Equivalents | 535.07M |
| Total Debt | 180.87M |
| Net Cash | 354.21M |
| Net Cash Per Share | 3.50 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 10.86 |
| Working Capital | 723.82M |
Cash Flow
In the last 12 months, operating cash flow was 63.83 million and capital expenditures -54.78 million, giving a free cash flow of 9.05 million.
| Operating Cash Flow | 63.83M |
| Capital Expenditures | -54.78M |
| Free Cash Flow | 9.05M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 49.11%, with operating and profit margins of 7.52% and 6.63%.
| Gross Margin | 49.11% |
| Operating Margin | 7.52% |
| Pretax Margin | 7.96% |
| Profit Margin | 6.63% |
| EBITDA Margin | 12.68% |
| EBIT Margin | 7.52% |
| FCF Margin | 1.04% |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 0.57%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | -77.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.60% |
| Buyback Yield | 2.14% |
| Shareholder Yield | 2.70% |
| Earnings Yield | 1.81% |
| FCF Yield | 0.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 23, 2024. It was a forward split with a ratio of 1.48.
| Last Split Date | May 23, 2024 |
| Split Type | Forward |
| Split Ratio | 1.48 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |